Nutriband Stock Performance
| NTRB Stock | USD 8.22 0.11 1.36% |
On a scale of 0 to 100, Nutriband holds a performance score of 10. The company secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nutriband's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nutriband is expected to be smaller as well. Please check Nutriband's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Nutriband's current price movements will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nutriband sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 492.9 K | |
| Total Cashflows From Investing Activities | -92 K |
Nutriband | Build AI portfolio with Nutriband Stock |
Nutriband Relative Risk vs. Return Landscape
If you would invest 523.00 in Nutriband on April 23, 2025 and sell it today you would earn a total of 299.00 from holding Nutriband or generate 57.17% return on investment over 90 days. Nutriband is currently generating 0.9859% in daily expected returns and assumes 7.3499% risk (volatility on return distribution) over the 90 days horizon. In different words, 65% of stocks are less volatile than Nutriband, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nutriband Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutriband's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nutriband, and traders can use it to determine the average amount a Nutriband's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1341
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NTRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.35 actual daily | 65 65% of assets are less volatile |
Expected Return
| 0.99 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Nutriband is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutriband by adding it to a well-diversified portfolio.
Nutriband Fundamentals Growth
Nutriband Stock prices reflect investors' perceptions of the future prospects and financial health of Nutriband, and Nutriband fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nutriband Stock performance.
| Return On Equity | -1.08 | ||||
| Return On Asset | -0.36 | ||||
| Operating Margin | (2.12) % | ||||
| Current Valuation | 87.58 M | ||||
| Shares Outstanding | 11.13 M | ||||
| Price To Earning | (15.98) X | ||||
| Price To Book | 17.69 X | ||||
| Price To Sales | 37.64 X | ||||
| Revenue | 2.14 M | ||||
| EBITDA | (10.18 M) | ||||
| Cash And Equivalents | 3.34 M | ||||
| Cash Per Share | 0.43 X | ||||
| Total Debt | 186.35 K | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (4.63 M) | ||||
| Earnings Per Share | (0.90) X | ||||
| Total Asset | 7.47 M | ||||
| Retained Earnings | (38.46 M) | ||||
| Current Asset | 33.76 K | ||||
| Current Liabilities | 13.08 K | ||||
About Nutriband Performance
By analyzing Nutriband's fundamental ratios, stakeholders can gain valuable insights into Nutriband's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nutriband has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nutriband has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Nutriband operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.Things to note about Nutriband performance evaluation
Checking the ongoing alerts about Nutriband for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nutriband help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nutriband is way too risky over 90 days horizon | |
| Nutriband appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.14 M. Net Loss for the year was (10.48 M) with profit before overhead, payroll, taxes, and interest of 830.51 K. | |
| Nutriband currently holds about 3.34 M in cash with (4.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43. | |
| Roughly 76.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Nutriband's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nutriband's stock is overvalued or undervalued compared to its peers.
- Examining Nutriband's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nutriband's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nutriband's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nutriband's stock. These opinions can provide insight into Nutriband's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nutriband Stock analysis
When running Nutriband's price analysis, check to measure Nutriband's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutriband is operating at the current time. Most of Nutriband's value examination focuses on studying past and present price action to predict the probability of Nutriband's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutriband's price. Additionally, you may evaluate how the addition of Nutriband to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |